Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    15201414 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Rituximab to Treat Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia
Conditions: Anemia, Aplastic;   Red-Cell Aplasia, Pure;   Anemia, Diamond-Blackfan
Intervention: Drug: Rituximab
2 Terminated Safety Study of Rituximab (Rituxan®) in Chronic Urticaria
Condition: Urticaria
Intervention: Drug: Rituximab
3 Unknown  Open Label Clinical Trial With Rituximab (MabThera ®) in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: rituximab
4 Completed
Has Results
Rituximab in New Onset Type 1 Diabetes
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Anti-CD20 (rituximab);   Drug: Placebo Comparator

Study has passed its completion date and status has not been verified in more than two years.